Daily FNArena News - Small Caps

Brokers continue to rate Judo Capital highly despite looming macroeconomic headwinds

Tim Boreham reports a change in CEO has given cancer monitoring biotech Impedimed a new lease of life

The ASX-listed AI sector can be split between tech providers developing AI tools and non-tech companies using AI to improve their existing business

Volpara Health Technologies is revolutionising breast cancer detection. Tim Boreham investigates

Cancer detection biotech Radiopharm Theronostics is planning to list on the Nasdaq, and not without good reason, Tim Boreham explains

It’s impossible to picture a future without cybersecurity. The ASX hosts a smorgasboard in potential exposures

Tim Boreham highlights the global addressable market opportunity for Avita Medical’s skin graft technology, made famous by the Bali bombings

Tapping into the Scandinavian market, Helloworld has acquired an interest in Norway-based Australiareiser, bringing its ResWorld platform to Europe

Following FY22 results for Telix Pharmaceuticals brokers remain Buy-rated in light of an extensive pipeline of new products under development

Amidst a sea of red, the Neuren share price has skyrocketed in recent days following a world first approval for the biotech’s treatment of Rett syndrome